For $55 million, Roche gains access to Manifold Bio’s drug discovery technology, which will be used to develop new “shuttles” that can get medicines across the blood-brain barrier.

Mathieu Roche,co-founder and CEO of ID5.io, highlights how his company, founded seven years ago, has become a leader in digital advertising. They achieved this by offering advanced custom models, ...

The uncertainty around the future of Elevidys hasn’t destroyed Roche’s belief in the potential of gene therapies, the Swiss company’s head of pharma has told Fierce Biotech, as the pharma continues to ...

With the lupus treatment landscape poised for a shake-up, Roche is hitting the scene in the U.S. with a new green light for its long-approved blood cancer medicine Gazyva. Early Monday, Roche’s ...

Everyone flirted with 89bio. Only Roche wanted to put a ring on it. In a financial filing, 89bio detailed the path from talks with numerous drugmakers to weeks of negotiations with Roche that ended in ...